These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
182 related articles for article (PubMed ID: 17512731)
1. Synthesis, bioactivity, theoretical and molecular docking study of 1-cyano-N-substituted-cyclopropanecarboxamide as ketol-acid reductoisomerase inhibitor. Liu XH; Chen PQ; Wang BL; Li YH; Wang SH; Li ZM Bioorg Med Chem Lett; 2007 Jul; 17(13):3784-8. PubMed ID: 17512731 [TBL] [Abstract][Full Text] [Related]
2. Conformational changes in a plant ketol-acid reductoisomerase upon Mg(2+) and NADPH binding as revealed by two crystal structures. Leung EW; Guddat LW J Mol Biol; 2009 May; 389(1):167-82. PubMed ID: 19362563 [TBL] [Abstract][Full Text] [Related]
3. Synthesis, bioactivity and SAR study of N'-(5-substituted-1,3,4-thiadiazol-2-yl)-N-cyclopropylformyl-thioureas as ketol-acid reductoisomerase inhibitors. Liu XH; Zhang CY; Guo WC; Li YH; Chen PQ; Wang T; Dong WL; Wang BL; Sun HW; Li ZM J Enzyme Inhib Med Chem; 2009 Apr; 24(2):545-52. PubMed ID: 18763167 [TBL] [Abstract][Full Text] [Related]
4. High throughput receptor-based virtual screening under ZINC database, synthesis, and biological evaluation of ketol-acid reductoisomerase inhibitors. Liu XH; Chen PQ; Wang BL; Dong WL; Li YH; Xie XQ; Li ZM Chem Biol Drug Des; 2010 Feb; 75(2):228-32. PubMed ID: 20028400 [TBL] [Abstract][Full Text] [Related]
5. Crystal structure of Mycobacterium tuberculosis ketol-acid reductoisomerase at 1.0 Å resolution - a potential target for anti-tuberculosis drug discovery. Lv Y; Kandale A; Wun SJ; McGeary RP; Williams SJ; Kobe B; Sieber V; Schembri MA; Schenk G; Guddat LW FEBS J; 2016 Apr; 283(7):1184-96. PubMed ID: 26876563 [TBL] [Abstract][Full Text] [Related]
6. Crystal Structures of Staphylococcus aureus Ketol-Acid Reductoisomerase in Complex with Two Transition State Analogues that Have Biocidal Activity. Patel KM; Teran D; Zheng S; Kandale A; Garcia M; Lv Y; Schembri MA; McGeary RP; Schenk G; Guddat LW Chemistry; 2017 Dec; 23(72):18289-18295. PubMed ID: 28975665 [TBL] [Abstract][Full Text] [Related]
7. Synthesis and biological activities of novel 5-substituted-1,3,4-oxadiazole Mannich bases and bis-Mannich bases as ketol-acid reductoisomerase inhibitors. Zhang Y; Liu XH; Zhan YZ; Zhang LY; Li ZM; Li YH; Zhang X; Wang BL Bioorg Med Chem Lett; 2016 Oct; 26(19):4661-4665. PubMed ID: 27575481 [TBL] [Abstract][Full Text] [Related]
8. Mechanism and Inhibitor Exploration with Binuclear Mg Ketol-Acid Reductoisomerase: Targeting the Biosynthetic Pathway of Branched-Chain Amino Acids. Yu MJ; Wu J; Chen SL Chembiochem; 2020 Feb; 21(3):381-391. PubMed ID: 31309701 [TBL] [Abstract][Full Text] [Related]
9. Discovery and evaluation of novel Mycobacterium tuberculosis ketol-acid reductoisomerase inhibitors as therapeutic drug leads. Krishna VS; Zheng S; Rekha EM; Guddat LW; Sriram D J Comput Aided Mol Des; 2019 Mar; 33(3):357-366. PubMed ID: 30666485 [TBL] [Abstract][Full Text] [Related]
11. Synthesis, crystal structure and herbicidal activity of mimics of intermediates of the KARI reaction. Wang BL; Duggleby RG; Li ZM; Wang JG; Li YH; Wang SH; Song HB Pest Manag Sci; 2005 Apr; 61(4):407-12. PubMed ID: 15751008 [TBL] [Abstract][Full Text] [Related]
12. Rational design based on bioactive conformation analysis of pyrimidinylbenzoates as acetohydroxyacid synthase inhibitors by integrating molecular docking, CoMFA, CoMSIA, and DFT calculations. He YZ; Li YX; Zhu XL; Xi Z; Niu C; Wan J; Zhang L; Yang GF J Chem Inf Model; 2007; 47(6):2335-44. PubMed ID: 17887745 [TBL] [Abstract][Full Text] [Related]
13. T-state inhibitors of E. coli aspartate transcarbamoylase that prevent the allosteric transition. Heng S; Stieglitz KA; Eldo J; Xia J; Cardia JP; Kantrowitz ER Biochemistry; 2006 Aug; 45(33):10062-71. PubMed ID: 16906764 [TBL] [Abstract][Full Text] [Related]
14. Inhibition studies of ketol-acid reductoisomerases from pathogenic microorganisms. Wun SJ; Johnson LA; You L; McGeary RP; Brueck T; Schenk G; Guddat LW Arch Biochem Biophys; 2020 Oct; 692():108516. PubMed ID: 32745463 [TBL] [Abstract][Full Text] [Related]
15. The crystal structure of a bacterial class II ketol-acid reductoisomerase: domain conservation and evolution. Tyagi R; Duquerroy S; Navaza J; Guddat LW; Duggleby RG Protein Sci; 2005 Dec; 14(12):3089-100. PubMed ID: 16322583 [TBL] [Abstract][Full Text] [Related]
16. Probing the mechanism of the bifunctional enzyme ketol-acid reductoisomerase by site-directed mutagenesis of the active site. Tyagi R; Lee YT; Guddat LW; Duggleby RG FEBS J; 2005 Jan; 272(2):593-602. PubMed ID: 15654896 [TBL] [Abstract][Full Text] [Related]
17. Characterization of the conformational changes of acetohydroxy acid isomeroreductase induced by the binding of Mg2+ ions, NADPH, and a competitive inhibitor. Halgand F; Dumas R; Biou V; Andrieu JP; Thomazeau K; Gagnon J; Douce R; Forest E Biochemistry; 1999 May; 38(19):6025-34. PubMed ID: 10320328 [TBL] [Abstract][Full Text] [Related]
18. Computer-aided design and synthesis of nonpeptidic plasmepsin II and IV inhibitors. Luksch T; Chan NS; Brass S; Sotriffer CA; Klebe G; Diederich WE ChemMedChem; 2008 Sep; 3(9):1323-36. PubMed ID: 18752222 [TBL] [Abstract][Full Text] [Related]
19. Achieving structural diversity using the perpendicular conformation of alpha-substituted phenylcyclopropanes to mimic the bioactive conformation of ortho-substituted biphenyl P4 moieties: discovery of novel, highly potent inhibitors of Factor Xa. Qiao JX; Cheney DL; Alexander RS; Smallwood AM; King SR; He K; Rendina AR; Luettgen JM; Knabb RM; Wexler RR; Lam PY Bioorg Med Chem Lett; 2008 Jul; 18(14):4118-23. PubMed ID: 18550370 [TBL] [Abstract][Full Text] [Related]
20. Design, synthesis and evaluation of isaindigotone derivatives as acetylcholinesterase and butyrylcholinesterase inhibitors. Pan L; Tan JH; Hou JQ; Huang SL; Gu LQ; Huang ZS Bioorg Med Chem Lett; 2008 Jul; 18(13):3790-3. PubMed ID: 18524585 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]